| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-61801-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-50146-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NB110-97867-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-09015-0.025mg | |||
![Western Blot: JNK3 Antibody (2B10H12) [NBP2-61801] - Analysis using MAPK10 mAb against HEK293 (1) and MAPK10 (AA: 180-329)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/JNK3-Antibody-2B10H12-Western-Blot-NBP2-61801-img0003.jpg "Western Blot: JNK3 Antibody (2B10H12) [NBP2-61801] - Analysis using MAPK10 mAb against HEK293 (1) and MAPK10 (AA: 180-329)-hIgGFc transfected HEK293 (2) cell lysate.")
![Western Blot: JNK3 Antibody (2B10H12) [NBP2-61801] - Analysis using MAPK10 mAb against human MAPK10 (AA: 180-329) recombinant protein. (Expected MW is 43.1 kDa)](http://images.novusbio.com/fullsize/JNK3-Antibody-2B10H12-Western-Blot-NBP2-61801-img0002.jpg)
![Western Blot: JNK3 Antibody (2B10H12) [NBP2-61801] - Analysis using MAPK10 mouse mAb against HEK293 (1), Hela (2), SK-N-SH (3), MCF-7 (4), Jurkat (5), and C6 (6) cell lysate.](http://images.novusbio.com/fullsize/JNK3-Antibody-2B10H12-Western-Blot-NBP2-61801-img0004.jpg)
![ELISA: JNK3 Antibody (2B10H12) [NBP2-61801] - Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)](http://images.novusbio.com/fullsize/JNK3-Antibody-2B10H12-ELISA-NBP2-61801-img0001.jpg)
![Immunohistochemistry-Paraffin: CD25/IL-2 R alpha Antibody (AP-MAB0710) [NB110-97867] - Formalin fixed and paraffin embedded mouse spleen tissue section was subjected to immunohistochemistry staining of CD25.](http://images.novusbio.com/fullsize/CD25-IL-2-R-alpha-Antibody-AP-MAB0710-Immunohistochemistry-Paraffin-NB110-97867-img0003.jpg "Immunohistochemistry-Paraffin: CD25/IL-2 R alpha Antibody (AP-MAB0710) [NB110-97867] - Formalin fixed and paraffin embedded mouse spleen tissue section was subjected to immunohistochemistry staining of CD25.")
![Western Blot: Lck Antibody (LCK-01) [NB500-336] - Fig. 1. Western Blotting analysis (reducing conditions) of human Lck in whole cell lysate using anti-human Lck (LCK-01). Lane 1: J. CaM-1.6 cell line (a mutant derivate of the JURKAT cell line) transfected with Lck Lane 2: HEK-293T cell line transfected with Lck Lane 3: HEK-293T cell line (non-transfected).](http://images.novusbio.com/fullsize/p_2373_1.jpg "Western Blot: Lck Antibody (LCK-01) [NB500-336] - Fig. 1. Western Blotting analysis (reducing conditions) of human Lck in whole cell lysate using anti-human Lck (LCK-01). Lane 1: J. CaM-1.6 cell line (a mutant derivate of the JURKAT cell line) transfected with Lck Lane 2: HEK-293T cell line transfected with Lck Lane 3: HEK-293T cell line (non-transfected).")
![Flow Cytometry: Lck Antibody (LCK-01) [NB500-336] - Staining of Lck in human peripheral blood cells using anti-Lck (LCK-01) Alexa Fluor® 647.](http://images.novusbio.com/fullsize/Lck-Antibody-LCK-01-Flow-Cytometry-NB500-336-img0002.jpg)
![Western Blot: CD3 zeta [p Tyr111] Antibody (EM-55) [NBP2-37709] - Cell lyzates of HEK293T/17 cells transiently transfected with expression vectors harboring genes for mCD3zeta wild type and six different mCD3zeta mutants, where particular ITAM tyrosines were substituted with phenylalanines, were prepared. Subsequently the lysates (non-reducing conditions) were immunoblotted with mouse mAb anti-pY111 mCD3zeta (clone EM-55).](http://images.novusbio.com/fullsize/CD3-zeta-p-Tyr111-Antibody-EM-55-Western-Blot-NBP2-37709-img0003.jpg "Western Blot: CD3 zeta [p Tyr111] Antibody (EM-55) [NBP2-37709] - Cell lyzates of HEK293T/17 cells transiently transfected with expression vectors harboring genes for mCD3zeta wild type and six different mCD3zeta mutants, where particular ITAM tyrosines were substituted with phenylalanines, were prepared. Subsequently the lysates (non-reducing conditions) were immunoblotted with mouse mAb anti-pY111 mCD3zeta (clone EM-55).")
![Western Blot: CD3 zeta [p tyr 111] Antibody (EM-55) [NBP2-37709] - Analysis in lysates of HEK293T/17 cells transiently transfected with expression vector harboring gene for mCD3zeta. Lane 1) Unstimulated cells, Lane 2) Pervanadate-stimulated cells](http://images.novusbio.com/fullsize/CD3-zeta-p-tyr-111-Antibody-EM-55-Western-Blot-NBP2-37709-img0001.jpg)
![Immunocytochemistry/Immunofluorescence: CD3 zeta [p Tyr72] Antibody (EM-26) [NBP2-62193] - Detection of phosphorylated CD3 zeta (EM-26; light blue) in immunological synapse formed between the lymph node naive T cells from AND TCR transgenic mice and DCEK cells loaded with MCC peptide, after 20 min. Total CD3 zeta indicated in green, actin cytoskeleton in red.](http://images.novusbio.com/fullsize/CD3-zeta-p-Tyr72-Antibody-EM-26-Immunocytochemistry-Immunofluorescence-NBP2-62193-img0003.jpg "Immunocytochemistry/Immunofluorescence: CD3 zeta [p Tyr72] Antibody (EM-26) [NBP2-62193] - Detection of phosphorylated CD3 zeta (EM-26; light blue) in immunological synapse formed between the lymph node naive T cells from AND TCR transgenic mice and DCEK cells loaded with MCC peptide, after 20 min. Total CD3 zeta indicated in green, actin cytoskeleton in red.")
![Western Blot: CD3 zeta [p Tyr72] Antibody (EM-26) [NBP2-62193] - Reactivity of the monoclonal antibodies EM-26 (anti-CD3 zeta phospho-Tyr72) and EM-17 (anti-CD3 zeta phospho-Tyr153) with phosphorylated particular human CD3 zeta mutants. The Y1F and Y6F mutatants lack phosphotyrosine 72 and 153, respectively.](http://images.novusbio.com/fullsize/CD3-zeta-p-Tyr72-Antibody-EM-26-Western-Blot-NBP2-62193-img0001.jpg)
![Immunohistochemistry-Paraffin: HLA DR/DP Antibody (HL-40) [NB500-408] - Immunohistochemistry staining of human small intestine (paraffin-embedded sections) with anti-HLA-DR/DP (HL-40).](http://images.novusbio.com/fullsize/HLA-DR-DP-Antibody-HL-40-Immunohistochemistry-Paraffin-NB500-408-img0001.jpg "Immunohistochemistry-Paraffin: HLA DR/DP Antibody (HL-40) [NB500-408] - Immunohistochemistry staining of human small intestine (paraffin-embedded sections) with anti-HLA-DR/DP (HL-40).")
![Immunocytochemistry/Immunofluorescence: MHC Class II Antibody (P7/7) - Chimeric [NBP3-09015] - Immunofluorescence analysis of paraformaldehyde fixed mouse splenocytes immobilized on Shi-fix(TM) cover-slips and stained with the chimeric rabbit IgG version of P7/7 (NBP3-09015) at 10 ug/ml followed by Alexa Fluor(R) 488 secondary antibody (2 ug/ml), showing membrane staining in a subset of cells. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-09015, DAPI, merged channels and an isotype control. The isotype control was stained with anti-Fluorescein antibody followed by Alexa Fluor(R) 488 secondary antibody.](http://images.novusbio.com/fullsize/MHC-Class-II-Antibody-P7-7-Chimeric-Immunocytochemistry-Immunofluorescence-NBP3-09015-img0002.jpg "Immunocytochemistry/Immunofluorescence: MHC Class II Antibody (P7/7) - Chimeric [NBP3-09015] - Immunofluorescence analysis of paraformaldehyde fixed mouse splenocytes immobilized on Shi-fix(TM) cover-slips and stained with the chimeric rabbit IgG version of P7/7 (NBP3-09015) at 10 ug/ml followed by Alexa Fluor(R) 488 secondary antibody (2 ug/ml), showing membrane staining in a subset of cells. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-09015, DAPI, merged channels and an isotype control. The isotype control was stained with anti-Fluorescein antibody followed by Alexa Fluor(R) 488 secondary antibody.")
![Flow Cytometry: MHC Class II Antibody (P7/7) - Chimeric [NBP3-09015] - Mouse splenocytes were stained with anti-Fluorescein IgG antibody (4-4-20; isotype control, black line) or the rabbit IgG1 version of P7/7 (NBP3-09015, blue line) at a dilution of 1:100 for 1h at RT. After washing, bound antibody was detected using a goat anti-mouse IgG AlexaFluor(R) 488 antibody at a dilution of 1:1000 and cells analyzed using a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/MHC-Class-II-Antibody-P7-7-Chimeric-Flow-Cytometry-NBP3-09015-img0001.jpg)
![Western Blot: CREB Antibody [NBP3-23243] - Western blot analysis of human A431 cells treated with calyculin A (100 nM) for 30 min. (lanes 1, 3 & 5) then the blots were treated with lambda phosphatase (lanes 2, 4 & 6). The blots were probed with anti-CREB (N-terminal region) (lanes 1 & 2), anti-CREB (Ser-133) (lanes 3 & 4), and anti-CREB (Ser-271) (lanes 5 & 6).](http://images.novusbio.com/fullsize/nbp3-23243_rabbit-creb-pab-19920231856929.jpg "Western Blot: CREB Antibody [NBP3-23243] - Western blot analysis of human A431 cells treated with calyculin A (100 nM) for 30 min. (lanes 1, 3 & 5) then the blots were treated with lambda phosphatase (lanes 2, 4 & 6). The blots were probed with anti-CREB (N-terminal region) (lanes 1 & 2), anti-CREB (Ser-133) (lanes 3 & 4), and anti-CREB (Ser-271) (lanes 5 & 6).")
![Immunocytochemistry/Immunofluorescence: CREB Antibody [NBP3-23243] - Immunocytochemical labeling of CREB in A431 that were fixed in paraformaldehyde and permeabilized using NP-40. The cells were labeled with rabbit polyclonal CREB (N-terminal region). The antibody was detected using goat anti-rabbit DyLight(R) 594.](http://images.novusbio.com/fullsize/nbp3-23243_rabbit-creb-pab-199202312523630.jpg)
![Immunocytochemistry/Immunofluorescence: CREB [p Ser271] Antibody [NBP3-23250] - Immunocytochemical labeling of phosphorylated CREB in control and calyculin A-treated A431 cells. The cells were fixed in paraformaldehyde and permeabilized using NP-40 before labeling with rabbit polyclonal CREB (Ser-271). The antibody was detected using goat anti-rabbit DyLight(R) 594.](http://images.novusbio.com/fullsize/nbp3-23250_rabbit-creb-p-ser271-pab-1992023199286.jpg "Immunocytochemistry/Immunofluorescence: CREB [p Ser271] Antibody [NBP3-23250] - Immunocytochemical labeling of phosphorylated CREB in control and calyculin A-treated A431 cells. The cells were fixed in paraformaldehyde and permeabilized using NP-40 before labeling with rabbit polyclonal CREB (Ser-271). The antibody was detected using goat anti-rabbit DyLight(R) 594.")
![Western Blot: CREB [p Ser271] Antibody [NBP3-23250] - Western blot analysis of human A431 cells treated with calyculin A (100 nM) for 30 min. (lanes 1, 3, & 5) then blots were treated with lambda phosphatase (lanes 2, 4, & 6). The blots were probed with anti-CREB (N-terminal region) (lanes 1 & 2), anti-CREB (Ser-133) (lanes 3 & 4), and anti-CREB (Ser-271) (lanes 5 & 6).](http://images.novusbio.com/fullsize/nbp3-23250_rabbit-creb-p-ser271-pab-189202317355213.jpg)